Organisation paid for research Program year 2022 Source: CMS Open Payments

Ztrials LLC

Neither a doctor nor a teaching hospital

Research payments

$274,252

118 payments

Through program year 2022, Ztrials LLC is reported as receiving $274,252 in research payments, across 118 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$3,692	1
2021	Research	$62,387	39
2020	Research	$72,533	56
2019	Research	$135,640	22

Breakdown

Who paid Research payments · program years 2019–2022

AbbVie, Inc. $274,252 118 payments

Studies the money was for Research payments · program years 2019–2022

M14-702 $200,173 76 payments
A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain $38,486 24 payments
A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Combined Oral Contraceptives in Premenopausal Women with Documented Endometriosis and Associated Moderate to Severe Pain $23,901 15 payments
M18-969 $8,000 2 payments
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain $3,692 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.